Asia-Pacific Sees Rising Adoption of Human Milk Oligosaccharides in Infant Nutrition and Functional Foods
The Human Milk Oligosaccharides (HMO) market has been witnessing significant growth due to the rising awareness of the health benefits associated with HMOs in infant nutrition and healthcare. HMOs are the third most abundant solid component in human milk, and their unique structure provides a wide range of functional benefits for infants, particularly in supporting gut health, immunity, and cognitive development. These naturally occurring sugars are not digested by infants but instead serve as prebiotics, promoting the growth of beneficial gut bacteria. HMOs also play a pivotal role in protecting infants against infections by acting as decoys for pathogens and stimulating immune responses.
The
global human milk oligosaccharides market size was valued at USD 255.86 million
in 2024. The market is projected to grow from USD 292.09 million in 2025 to USD
1,821.29 million by 2034, exhibiting a CAGR of 22.60% during 2025–2034.
With
the increasing adoption of HMOs in infant formula products and the growing
focus on early childhood nutrition, the demand for human milk oligosaccharides
has been rising globally. As a result, the HMO market is expected to continue
its upward trajectory as innovations in technology and advancements in
production methods, such as microbial fermentation, make the extraction and
inclusion of HMOs in various products more feasible.
The
global HMO market is influenced by factors such as a growing number of working
mothers, increased consumption of infant formula, and a higher focus on baby
health. Additionally, the expanding scope of HMO-based applications in
pharmaceutical and nutraceutical industries, such as gut health, immune
support, and cognitive development, is also contributing to the growth of this
market.
Market
Trends
The
demand for HMOs is driven primarily by their applications in infant nutrition,
but their use is now expanding beyond infant formulas into adult nutrition and
therapeutics. In particular, the growing awareness of the microbiome's impact
on health is pushing the demand for prebiotics like HMOs, which are gaining
traction as functional food ingredients. Furthermore, the rising preference for
natural and organic ingredients in food and healthcare products is also
boosting the market for HMOs.
1.
Rising Demand for Infant Nutrition Products
As
the global birth rate declines and the number of working mothers increases, the
demand for infant formula containing HMOs is expanding. These products are
designed to mimic the nutritional composition of breast milk, providing
essential nutrients for infant development. Consequently, manufacturers are
investing in HMO technologies to enhance the quality and bioavailability of
infant formulas. In countries such as the United States, Germany, and China,
where infant formula consumption is on the rise, HMO inclusion is seen as a key
differentiator for premium infant nutrition products.
2.
Health and Wellness Trends
The
shift toward preventative healthcare and wellness is influencing the growth of
the HMO market. In both developed and developing countries, consumers are
becoming more health-conscious and are increasingly seeking products that can
support their immune system and digestive health. As HMOs are scientifically
proven to aid in immune system development, gut health, and reduce the
incidence of infections, they are gaining popularity not only in baby foods but
also in adult nutrition products such as functional beverages and dietary
supplements.
3.
Innovations in HMO Production
Technological
advancements are playing a pivotal role in shaping the future of the HMO
market. Traditional methods of extracting HMOs from human milk are costly and
inefficient, prompting manufacturers to explore more cost-effective methods,
such as microbial fermentation. This innovation has made it possible to produce
HMOs on a commercial scale, further driving market growth. With the increasing
availability of high-quality, cost-effective HMOs, manufacturers are able to
incorporate these oligosaccharides into a wider range of products, thus
expanding the market.
4.
Regulatory Developments
Regulations
regarding the use of HMOs in food and healthcare products vary significantly
from country to country. In several regions, regulatory bodies such as the
European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration
(FDA) are providing guidelines for the safe use of HMOs in infant formula and
other products. As these regulations evolve and more studies prove the safety
and efficacy of HMOs, it is expected that more markets will open up for the
inclusion of HMOs in consumer goods.
Country-Wise
Market Analysis
The
HMO market shows varied growth trends across different regions, influenced by
factors such as local regulations, consumer preferences, and the rate of
adoption of new nutrition technologies. The following is a country-wise
analysis of the HMO market:
1.
United States
The
U.S. is a significant market for HMOs, primarily driven by the rising demand
for infant formula products. As one of the largest consumers of infant
nutrition products globally, the U.S. presents a large market for manufacturers
of HMO-based products. The demand for HMO-infused formulas is growing as
consumers increasingly prefer products that closely mimic the nutritional
benefits of breast milk. Furthermore, the focus on healthy aging and gut health
among U.S. consumers is contributing to the growth of the HMO market in
functional foods and dietary supplements. Additionally, supportive regulatory
frameworks and rising healthcare awareness are expected to continue driving the
market in this region.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞
@ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market
2.
China
China
is another dominant market for HMOs, primarily driven by its large population
and the increasing demand for infant formula. The growing awareness of the
health benefits of breastfeeding, coupled with a rising middle-class
population, has led to a significant increase in the demand for HMO-infused
infant nutrition products. Furthermore, the rapid urbanization in China, along
with an increasing number of working mothers, has further accelerated the
consumption of infant formula. The Chinese market is expected to grow at a high
rate, supported by government initiatives and a surge in demand for premium and
health-oriented products.
3.
Germany
Germany
is a leading market for HMOs in Europe, particularly due to the country’s
strong healthcare and nutrition sectors. The demand for infant formula enriched
with HMOs is increasing, driven by the rising adoption of advanced,
science-backed infant nutrition solutions. Germany’s strong emphasis on natural
and organic food ingredients also supports the growth of the HMO market.
Additionally, Germany’s role as a hub for healthcare and pharmaceutical
innovations contributes to a rising interest in the therapeutic applications of
HMOs, especially in the field of gut health.
4.
India
In
India, the demand for HMOs in infant nutrition products is also gaining
momentum. The country has a large population of newborns, and the increasing
disposable income among middle-class families is driving the consumption of
premium baby food products. However, due to the strong cultural preference for
breastfeeding, the adoption of infant formulas is still relatively lower
compared to Western countries. Despite this, as urbanization increases and
working mothers face time constraints, the demand for HMO-enriched formulas is
expected to rise steadily in the coming years. Additionally, India’s growing
interest in functional foods and health supplements is contributing to the
increasing use of HMOs in adult nutrition products.
5.
Brazil
Brazil
is one of the key emerging markets for HMOs in Latin America. The country has a
large infant population, and there is a growing preference for premium and
nutritionally enhanced infant formula. As healthcare awareness increases,
Brazilian consumers are becoming more conscious of the nutritional benefits of
HMOs. Furthermore, the increasing interest in functional foods and dietary
supplements that support immune function and digestive health is expected to
drive the demand for HMOs in Brazil. The regulatory landscape in Brazil is also
evolving, with a focus on ensuring the safety and efficacy of new ingredients
in food and healthcare products.
6.
Japan
Japan
has a mature market for infant nutrition, and there is a growing demand for
high-quality, science-backed products. The country's aging population has
contributed to the rising interest in functional foods, especially those
promoting gut health, immune function, and cognitive development. As a result,
the inclusion of HMOs in both infant formulas and adult functional foods is
gaining popularity in Japan. Moreover, Japan’s advanced healthcare system and
high awareness of the benefits of prebiotics like HMOs further bolster the
market’s potential in the region.
Conclusion
The
global Human
Milk Oligosaccharides (HMO) market is poised for significant growth, driven
by the increasing demand for infant nutrition products and the expanding
applications of HMOs in functional foods and therapeutics. As consumer
awareness of the health benefits of HMOs continues to rise, coupled with
advancements in production technologies, the market is expected to continue to
expand. Regional dynamics, including varying consumer preferences and
regulatory landscapes, will play an important role in shaping the future of the
HMO market.
More
Trending Latest Reports By Polaris Market Research:
Biologics
Safety Testing Market
Lecithin and
Phospholipids Market
Comments
Post a Comment